CHRONIC LIVER ALLOGRAFT REJECTION IN A POPULATION TREATED PRIMARILY WITH TACROLIMUS AS BASELINE IMMUNOSUPPRESSION

Abstract

Early chronic liver allograft rejection is potentially reversible and a combination of histological, clinical, and laboratory data can be used to stage CR. Unique immunological and regenerative properties of liver allografts, which lead to a low incidence and reversibility of early CR, can provide insights into transplantation biology.